Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
4,263,282
-
Shares change
-
-751,096
-
Total reported value, excl. options
-
$22,466,330
-
Value change
-
-$3,507,299
-
Put/Call ratio
-
10.02%
-
Number of buys
-
13
-
Number of sells
-
-24
-
Price
-
$5.27
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q3 2022
57 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q3 2022.
AVITA Medical, Inc. - Common Stock (RCEL) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,263,282 shares
of 26,475,256 outstanding shares and own 16.1% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,147,755 shares), PURA VIDA INVESTMENTS, LLC (858,951 shares), BlackRock Inc. (474,383 shares), GEODE CAPITAL MANAGEMENT, LLC (251,958 shares), RENAISSANCE TECHNOLOGIES LLC (238,580 shares), MILLENNIUM MANAGEMENT LLC (180,242 shares), Polar Asset Management Partners Inc. (153,600 shares), AMERIPRISE FINANCIAL INC (149,687 shares), Caption Management, LLC (106,959 shares), and Ergoteles LLC (94,004 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.